127 related articles for article (PubMed ID: 22363982)
1. [Regulation of soluble guanylyl cyclase and its role in the treatment of cardiovascular diseases].
Guan WL; Dou D; Gao YS
Sheng Li Ke Xue Jin Zhan; 2011 Dec; 42(6):431-6. PubMed ID: 22363982
[No Abstract] [Full Text] [Related]
2. Soluble guanylate cyclase: not a dull enzyme.
Boerrigter G; Burnett JC
Circulation; 2009 Jun; 119(21):2752-4. PubMed ID: 19451346
[No Abstract] [Full Text] [Related]
3. Deconstructing endothelial dysfunction: soluble guanylyl cyclase oxidation and the NO resistance syndrome.
Gladwin MT
J Clin Invest; 2006 Sep; 116(9):2330-2. PubMed ID: 16955136
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Boerrigter G; Burnett JC
Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
[TBL] [Abstract][Full Text] [Related]
5. Is the soluble guanylate cyclase pathway the only one available for nitric oxide (NO) signaling?
Landar A; Darley-Usmar VM
IUBMB Life; 2007 Feb; 59(2):110-2. PubMed ID: 17454303
[No Abstract] [Full Text] [Related]
6. Direct fusion of subunits of heterodimeric nitric oxide sensitive guanylyl cyclase leads to functional enzymes with preserved biochemical properties: evidence for isoform specific activation by ciguates.
Haase N; Haase T; Kraehling JR; Behrends S
Biochem Pharmacol; 2010 Dec; 80(11):1676-83. PubMed ID: 20797390
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60-2770 in experimental liver fibrosis.
Knorr A; Hirth-Dietrich C; Alonso-Alija C; Härter M; Hahn M; Keim Y; Wunder F; Stasch JP
Arzneimittelforschung; 2008; 58(2):71-80. PubMed ID: 18412020
[TBL] [Abstract][Full Text] [Related]
8. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].
Severina IS
Biomed Khim; 2007; 53(4):385-99. PubMed ID: 18035720
[TBL] [Abstract][Full Text] [Related]
9. Insights into soluble guanylyl cyclase activation derived from improved heme-mimetics.
Rekowski MVW; Kumar V; Zhou Z; Moschner J; Marazioti A; Bantzi M; Spyroulias GA; van den Akker F; Giannis A; Papapetropoulos A
J Med Chem; 2013 Nov; 56(21):8948-8952. PubMed ID: 24090476
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide- and heme-independent activation of soluble guanylate cyclase attenuates peroxynitrite-induced endothelial dysfunction in rat aorta.
Korkmaz S; Loganathan S; Mikles B; Radovits T; Barnucz E; Hirschberg K; Li S; Hegedüs P; Páli S; Weymann A; Karck M; Szabó G
J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):70-7. PubMed ID: 22914857
[TBL] [Abstract][Full Text] [Related]
11. Receptor binding assay for NO-independent activators of soluble guanylate cyclase.
Schmidt PM; Stasch JP
Methods Mol Biol; 2013; 1020():205-14. PubMed ID: 23709035
[TBL] [Abstract][Full Text] [Related]
12. NO-independent activators of soluble guanylate cyclase: therapeutic potential.
Mathew R
Am J Hypertens; 2009 May; 22(5):470. PubMed ID: 19387430
[No Abstract] [Full Text] [Related]
13. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle.
Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E
Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622
[TBL] [Abstract][Full Text] [Related]
14. Role of soluble guanylate cyclase in renal hemodynamics and autoregulation in the rat.
Dautzenberg M; Kahnert A; Stasch JP; Just A
Am J Physiol Renal Physiol; 2014 Nov; 307(9):F1003-12. PubMed ID: 25209860
[TBL] [Abstract][Full Text] [Related]
15. [Potentiation of NO-dependent activation of soluble guanylate cyclase by polyamines].
Severina IS; Piatakova NV; Shchegolev AIu
Biomed Khim; 2007; 53(1):44-9. PubMed ID: 17436683
[TBL] [Abstract][Full Text] [Related]
16. [Potentiation of nitric oxide-dependent activation of soluble guanylate cyclase by levomycetin, tetracycline, and oxolin].
Shchegolev AIu; Sidorova TA; Severina IS
Biomed Khim; 2009; 55(3):331-7. PubMed ID: 19663005
[TBL] [Abstract][Full Text] [Related]
17. [YC-1-like potentiation of nitric oxide-dependent activation of soluble guanylyl cyclase by adrenochrome].
Severina IS; Piatakova NV; Shchegolev AIu; Sidorova TA
Biomed Khim; 2008; 54(6):679-86. PubMed ID: 19205427
[TBL] [Abstract][Full Text] [Related]
18. Regulation of soluble guanylyl cyclase activity by oestradiol and progesterone in the hypothalamus but not hippocampus of female rats.
Reyna-Neyra A; Sarkar G; Etgen AM
J Neuroendocrinol; 2007 Jun; 19(6):418-25. PubMed ID: 17388815
[TBL] [Abstract][Full Text] [Related]
19. Molecular variants of soluble guanylyl cyclase affecting cardiovascular risk.
Wobst J; Rumpf PM; Dang TA; Segura-Puimedon M; Erdmann J; Schunkert H
Circ J; 2015; 79(3):463-9. PubMed ID: 25746521
[TBL] [Abstract][Full Text] [Related]
20. Regulation of nitric oxide-sensitive guanylyl cyclase.
Friebe A; Koesling D
Circ Res; 2003 Jul; 93(2):96-105. PubMed ID: 12881475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
